WhatsApp and atopic dermatitis: a clinical trial
Objective: To evaluate the effect of text messages with information about atopic dermatitis (AD) on the quality of life (QoL) of children and their caregivers and on the severity of the disease. Methods: Researcher-blinded randomized controlled clinical trial. The experimental group (EG) received me...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-01-01
|
| Series: | Jornal de Pediatria |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S0021755724000901 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1841560554254106624 |
|---|---|
| author | Thaís Braga Cerqueira Renata Robl Imoto Mariana Muzzolon Vânia Oliveira de Carvalho |
| author_facet | Thaís Braga Cerqueira Renata Robl Imoto Mariana Muzzolon Vânia Oliveira de Carvalho |
| author_sort | Thaís Braga Cerqueira |
| collection | DOAJ |
| description | Objective: To evaluate the effect of text messages with information about atopic dermatitis (AD) on the quality of life (QoL) of children and their caregivers and on the severity of the disease. Methods: Researcher-blinded randomized controlled clinical trial. The experimental group (EG) received messages about AD and the control group (CG) about general health. A total of 56 children under 15 years of age and their caregivers, allocated to the CG and EG, were assessed on admission, after one month, and after four months. Improvement in QoL was measured by the Children's Dermatology Life Quality Index (CDLQI), the Infants’ Dermatitis Quality of Life Index (IDQOL), and the Dermatitis Family Impact Questionnaire (DFIQ), and improvement in the severity of AD by the Scoring of Atopic Dermatitis (SCORAD) and the Eczema Area and Severity Index (EASI). Results: Median age was of nine years, 33 (58.9 %) were girls. The CG and EG had similar results, except for the higher frequency of mild AD in the CG and moderate/severe AD in the EG—these severity categories were kept grouped together. Regarding mild and moderate/severe AD in the EG, the SCORAD score decreased (p = 0.03 and p < 0.001). The EASI in both groups showed a significant reduction (mild AD: CG: p = 0.01, EG: p = 0.04; moderate/severe AD: CG: p = 0.05, EG: p = 0.02). The QoL of children and caregivers improved only in the EG (p = 0.01). Intergroup analysis showed no differences. Conclusion: The improvement in the severity of AD in both groups suggests the positive effects of educational interventions in general, not only those specific to the disease. |
| format | Article |
| id | doaj-art-551ea54fa6f44ff0a200a51c12f4a318 |
| institution | Kabale University |
| issn | 0021-7557 |
| language | English |
| publishDate | 2025-01-01 |
| publisher | Elsevier |
| record_format | Article |
| series | Jornal de Pediatria |
| spelling | doaj-art-551ea54fa6f44ff0a200a51c12f4a3182025-01-04T04:55:46ZengElsevierJornal de Pediatria0021-75572025-01-0110116773WhatsApp and atopic dermatitis: a clinical trialThaís Braga Cerqueira0Renata Robl Imoto1Mariana Muzzolon2Vânia Oliveira de Carvalho3Programa de Pós-Graduação em Dermatologia Pediátrica, Universidade Federal do Paraná (UFPR), Curitiba, PR, Brazil; Corresponding author.Programa de Pós-Graduação em Saúde da Criança e do Adolescente, Complexo do Hospital de Clínicas, Universidade Federal do Paraná (UFPR), Curitiba, PR, BrazilPrograma de Pós-Graduação em Saúde da Criança e do Adolescente, Complexo do Hospital de Clínicas, Universidade Federal do Paraná (UFPR), Curitiba, PR, BrazilPrograma de Pós-Graduação em Saúde da Criança e do Adolescente, Complexo do Hospital de Clínicas, Universidade Federal do Paraná (UFPR), Curitiba, PR, BrazilObjective: To evaluate the effect of text messages with information about atopic dermatitis (AD) on the quality of life (QoL) of children and their caregivers and on the severity of the disease. Methods: Researcher-blinded randomized controlled clinical trial. The experimental group (EG) received messages about AD and the control group (CG) about general health. A total of 56 children under 15 years of age and their caregivers, allocated to the CG and EG, were assessed on admission, after one month, and after four months. Improvement in QoL was measured by the Children's Dermatology Life Quality Index (CDLQI), the Infants’ Dermatitis Quality of Life Index (IDQOL), and the Dermatitis Family Impact Questionnaire (DFIQ), and improvement in the severity of AD by the Scoring of Atopic Dermatitis (SCORAD) and the Eczema Area and Severity Index (EASI). Results: Median age was of nine years, 33 (58.9 %) were girls. The CG and EG had similar results, except for the higher frequency of mild AD in the CG and moderate/severe AD in the EG—these severity categories were kept grouped together. Regarding mild and moderate/severe AD in the EG, the SCORAD score decreased (p = 0.03 and p < 0.001). The EASI in both groups showed a significant reduction (mild AD: CG: p = 0.01, EG: p = 0.04; moderate/severe AD: CG: p = 0.05, EG: p = 0.02). The QoL of children and caregivers improved only in the EG (p = 0.01). Intergroup analysis showed no differences. Conclusion: The improvement in the severity of AD in both groups suggests the positive effects of educational interventions in general, not only those specific to the disease.http://www.sciencedirect.com/science/article/pii/S0021755724000901Atopic dermatitisHealth educationQuality of lifePediatricsText message |
| spellingShingle | Thaís Braga Cerqueira Renata Robl Imoto Mariana Muzzolon Vânia Oliveira de Carvalho WhatsApp and atopic dermatitis: a clinical trial Jornal de Pediatria Atopic dermatitis Health education Quality of life Pediatrics Text message |
| title | WhatsApp and atopic dermatitis: a clinical trial |
| title_full | WhatsApp and atopic dermatitis: a clinical trial |
| title_fullStr | WhatsApp and atopic dermatitis: a clinical trial |
| title_full_unstemmed | WhatsApp and atopic dermatitis: a clinical trial |
| title_short | WhatsApp and atopic dermatitis: a clinical trial |
| title_sort | whatsapp and atopic dermatitis a clinical trial |
| topic | Atopic dermatitis Health education Quality of life Pediatrics Text message |
| url | http://www.sciencedirect.com/science/article/pii/S0021755724000901 |
| work_keys_str_mv | AT thaisbragacerqueira whatsappandatopicdermatitisaclinicaltrial AT renataroblimoto whatsappandatopicdermatitisaclinicaltrial AT marianamuzzolon whatsappandatopicdermatitisaclinicaltrial AT vaniaoliveiradecarvalho whatsappandatopicdermatitisaclinicaltrial |